Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7633350 | 0.84 | GLRA1 (0.32) | GLRA1SLC6A9OR51E2 | |
| SCHEMBL98566 | 0.80 | GLRA1 (0.47) | ADRA1AGLRA1SLC6A9OR51E2 | |
| SCHEMBL27659749 | 0.80 | MEN1 (0.43) | — | |
| SCHEMBL7872934 | 0.79 | — | — | |
| SCHEMBL15090435 | 0.78 | PSMB5 (0.31) | — | |
| SCHEMBL6841493 | 0.77 | GLRA1 (0.30) | GLRA1SLC6A9OR51E2 | |
| SCHEMBL21955799 | 0.77 | GLRA1 (0.39) | ADRA1AGLRA1SLC6A9OR51E2 | |
| SCHEMBL8347563 | 0.74 | PTGS1 (0.35) | — | |
| SCHEMBL27606643 | 0.73 | MEN1 (0.31) | — | |
| SCHEMBL15136399 | 0.73 | MVD (0.39) | ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102358752-B | GLP-1 and exendin related invention | PHILIPPS UNIVERSITY MARBURG | 2014-07-30 | — | — | CN | claimed |
| CN-102358752-A | GLP-1 and exendin related invention | PHILIPPS UNIVERSITY MARBURG | 2012-02-22 | — | — | CN | claimed |
| CN-102304179-A | With GLP-1 and the relevant invention of incretin analogue (exendin) | UNIV MARBURG PHILIPPS | 2012-01-04 | — | — | CN | claimed |
| CN-101010340-A | Invention relating to GLP-1 and incretin analogue (exendin) | UNIV MARBURG PHILIPPS (DE) | 2007-08-01 | — | — | CN | claimed |
| EP-2311452-B2 | Topical composition comprising n-acetyl glucosamine | YU RUEY J (US) | 2020-12-30 | — | — | EP | disclosed |
| EP-2311452-B9 | Topical composition comprising n-acetyl glucosamine | YU RUEY J (US) | 2014-12-24 | — | — | EP | disclosed |
| CN-102358752-B | GLP-1 and exendin related invention | PHILIPPS UNIVERSITY MARBURG | 2014-07-30 | — | — | CN | disclosed |
| US-RE44302-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | YU RUEY J (US) | 2013-06-18 | — | — | US | disclosed |
| US-RE44017-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | YU RUEY J (US) | 2013-02-19 | — | — | US | disclosed |
| CN-101010340-B | Invention relating to GLP-1 and incretin analogue (exendin) | UNIV MARBURG PHILIPPS | 2012-11-28 | — | — | CN | disclosed |
| CN-102358752-A | GLP-1 and exendin related invention | PHILIPPS UNIVERSITY MARBURG | 2012-02-22 | — | — | CN | disclosed |
| CN-102304179-A | With GLP-1 and the relevant invention of incretin analogue (exendin) | UNIV MARBURG PHILIPPS | 2012-01-04 | — | — | CN | disclosed |
| CN-101010340-A | Invention relating to GLP-1 and incretin analogue (exendin) | UNIV MARBURG PHILIPPS (DE) | 2007-08-01 | — | — | CN | disclosed |
| EP-1639994-A2 | Topical composition comprising N-acetylaldosamines or N-acetylamino acids | Yu, Ruey J., Dr. (US) | 2006-03-29 | — | — | EP | disclosed |
| EP-1570840-A2 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2005-09-07 | — | — | EP | disclosed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | disclosed |
| CN-1361766-A | Tricyclic compounds having acyloxymethoxycarbonyl side chain | SHIONOGI PHARMACEUTICAL & CO L (JP) | 2002-07-31 | — | — | CN | disclosed |
| EP-1143925-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | disclosed |
| WO-2000040217-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-07-13 | — | — | WO | disclosed |